MicroRNA-19b exacerbates systemic sclerosis through promoting Th9 cells

Area of Science:

• Immunology
• Molecular Biology
• Autoimmune Diseases

Background:

• Systemic sclerosis (SSc) is a complex autoimmune disorder marked by widespread fibrosis.
• The precise immunological mechanisms driving SSc pathogenesis are not fully understood.

Purpose of the Study:

• To investigate the role of microRNA-19b (miR-19b) in the development and progression of SSc.
• To elucidate the molecular pathways through which miR-19b influences T helper 9 (Th9) cell activity in SSc.

Main Methods:

• Utilized a bleomycin-induced mouse model of SSc.
• Analyzed CD4+ T cells for miR-19b and IL-9 expression.
• Investigated the molecular mechanisms involving TGF-β, IL-4, NLRC3, TRAF6, TAK1, NF-κB, and E2f8.
• Correlated miR-19b and IL-9 levels with disease severity in SSc patients.

Main Results:

• miR-19b and IL-9 levels are elevated in CD4+ T cells in experimental SSc.
• Inhibition of miR-19b reduced Th9 cells and ameliorated SSc symptoms in mice.
• A molecular pathway involving TGF-β, IL-4, NLRC3, TRAF6, TAK1, and NF-κB was identified, leading to miR-19b upregulation.
• miR-19b directly upregulates IL-9 by suppressing E2f8.
• Increased IL-9 and MIR-19B levels in SSc patients correlate with disease severity.

Conclusions:

• miR-19b is a critical mediator in Th9 cell-driven SSc pathogenesis.
• Targeting miR-19b presents a potential therapeutic strategy for managing SSc.